Zenker P N, Rolfs R T
Division of STD/HIV Prevention, Centers for Disease Control, Atlanta, Georgia 30333.
Rev Infect Dis. 1990 Jul-Aug;12 Suppl 6:S590-609. doi: 10.1093/clinids/12.supplement_6.s590.
With the introduction of penicillin after World War II, the incidence of syphilis in the United States decreased. Because of penicillin's great success, clinical trials stopped after an initial period of intensive investigation. Syphilis is a difficult disease to study; the natural history may span decades in an individual, and diagnosis and outcome are usually defined serologically, not clinically or bacteriologically. Although the recommended penicillin regimens changed, clinical trials were not repeated. Furthermore, because the early studies occurred before modern clinical-trial methodology was developed, interpretation of the results is difficult. As a result, while current regimens for syphilis therapy are effective, they may or may not be optimal. With the accumulation of reports of treatment failures and the recent appearance of human immunodeficiency virus, current regimens for the treatment of syphilis are being questioned. As background for a meeting at which treatment guidelines were reviewed, the available literature on syphilis therapy is summarized herein.
二战后随着青霉素的引入,美国梅毒发病率有所下降。由于青霉素取得了巨大成功,在经过初期的深入研究后临床试验就停止了。梅毒是一种难以研究的疾病;其自然病程在个体中可能长达数十年,而且诊断和结果通常通过血清学来界定,而非临床或细菌学方法。尽管推荐的青霉素治疗方案有所变化,但并未重复进行临床试验。此外,由于早期研究是在现代临床试验方法学发展之前进行的,结果的解读存在困难。因此,虽然目前的梅毒治疗方案是有效的,但它们可能是最优的,也可能不是。随着治疗失败报告的不断积累以及近期人类免疫缺陷病毒的出现,当前的梅毒治疗方案正受到质疑。作为一次审查治疗指南会议的背景资料,本文总结了关于梅毒治疗的现有文献。